Stem cells: a new strategy for treatment of(4) - 上海经济研究杂志社投稿_期刊论文发表|版面费|电话|编辑部|论文发表- 上海经济研究

一、稿件要求： 1、稿件内容应该是与某一计算机类具体产品紧密相关的新闻评论、购买体验、性能详析等文章。要求稿件论点中立，论述详实，能够对读者的购买起到指导作用。文章体裁不限，字数不限。 2、稿件建议采用纯文本格式(*.txt)。如果是文本文件，请注明插图位置。插图应清晰可辨，可保存为*.jpg、*.gif格式。如使用word等编辑的文本，建议不要将图片直接嵌在word文件中，而将插图另存，并注明插图位置。 3、如果用电子邮件投稿，最好压缩后发送。 4、请使用中文的标点符号。例如句号为。而不是.。 5、来稿请注明作者署名(真实姓名、笔名)、详细地址、邮编、联系电话、E-mail地址等，以便联系。 6、我们保留对稿件的增删权。 7、我们对有一稿多投、剽窃或抄袭行为者，将保留追究由此引起的法律、经济责任的权利。二、投稿方式： 1、请使用电子邮件方式投递稿件。 2、编译的稿件，请注明出处并附带原文。 3、请按稿件内容投递到相关编辑信箱三、稿件著作权： 1、投稿人保证其向我方所投之作品是其本人或与他人合作创作之成果，或对所投作品拥有合法的著作权，无第三人对其作品提出可成立之权利主张。 2、投稿人保证向我方所投之稿件，尚未在任何媒体上发表。 3、投稿人保证其作品不含有违反宪法、法律及损害社会公共利益之内容。 4、投稿人向我方所投之作品不得同时向第三方投送，即不允许一稿多投。若投稿人有违反该款约定的行为，则我方有权不向投稿人支付报酬。但我方在收到投稿人所投作品10日内未作出采用通知的除外。 5、投稿人授予我方享有作品专有使用权的方式包括但不限于：通过网络向公众传播、复制、摘编、表演、播放、展览、发行、摄制电影、电视、录像制品、录制录音制品、制作数字化制品、改编、翻译、注释、编辑，以及出版、许可其他媒体、网站及单位转载、摘编、播放、录制、翻译、注释、编辑、改编、摄制。 6、投稿人委托我方声明，未经我方许可，任何网站、媒体、组织不得转载、摘编其作品。

Stem cells: a new strategy for treatment of(4)

作者:

关键词:

摘要：

[3] Chang CY, Lin HJ, Li BR, et al.A novel metallo-βlactamase involved in the ampicillin resistance of Streptococcus pneumoniae ATCC 49 136 strain[J].PLoS One, 2016, 11(5):e0.

[4] Huang S, Liu X, Lao W, et distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013[J].BMC Infect Dis, 2015, 15:312.

[5] Olesen B, Juhl-J?rgensen A, Tronier S, et al.A new successful approach to combating vancomycin-resistant enterococcus[J].J Hosp Infect, 2015, 91(4):375-376.

[6] Barber KE, Smith JR, Raut A, et of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid[J].J Antimicrob Chemother, 2016, 71(1):152-155.

[7] Du H, Chen L, Tang YW, et of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae[J].Lancet Infect Dis, 2016, 16(3):287-288.

[8] Moxon CA, Paulus in Enterobacteriaceae infections in children[J].J Infect, 2016, 72(Suppl):S41-S49.

[9] Khong WX, Xia E, Marimuthu K, et al.Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis[J].BMC Genomics, 2016, 17:452.

[10] Tada T, Miyoshi-Akiyama T, Shimada K, et and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa[J].Antimicrob Agents Chemother, 2013, 57(9):4427-4432.

[11] Ghasemi F, Jalal action of zinc oxide nanoparticles in combination with ciprofloxacin and ceftazidime against multidrug-resistant Acinetobacter baumannii[J].J Glob Antimicrob Resist, 2016, 6:118-122.

[12] Tada T, Miyoshi-Akiyama T, Dahal RK, et of a novel 6’-N-aminoglycoside acetyltransferase, AAC(6’)-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia[J].Antimicrob Agents Chemother, 2014, 58(10):6324-6327.

[13] Hajian B, Scocchera E, Keshipeddy S, et antifolates are potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis[J].PLoS One, 2016, 11(8):e0.

[14] Georghiou SB, Seifert M, Lin SY, et light on the performance of a pyrosequencing assay for drugresistant tuberculosis diagnosis[J].BMC Infect Dis, 2016,16(1):458.

[15] Gerlich MG, Piegsa J, Sch?fer C, et hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study[J].BMC Infect Dis, 2015, 15:441.

[16] Rogers BA, Aminzadeh Z, Hayashi Y, et transfer of patients and the risk of multi-resistant bacterial infection[J].Clin Infect Dis, 2011, 53(1):49-56.

[17] Magiorakos AP, Srinivasan A, Carey RB, et , extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect, 2012, 18(3):268-281.

[18] Zumla A, Raviglione M, Hafner R, et [J].N Engl J Med, 2013, 368(8):745-755.

[19] Kalokhe AS, Shafiq M, Lee JC, et tuberculosis drug susceptibility and molecular diagnostic testing[J].Am J Med Sci, 2013, 345(2):143-148.

[20] Goldberg DE, Siliciano RF, Jacobs evolution: fi ghting drug-resistant TB, malaria, and HIV[J].Cell, 2012, 148(6):1271-1283.

[21] Wright J, Paauw of antibiotic therapy[J].Med Clin North Am, 2013, 97(4):667-679.

[22] Sundaram V, Kowdley of chronic hepatitis B infection[J].BMJ, 2015, 351:h4263.

[23] Kim SS, Cho SW, Kim SO, et hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy[J].J Med Virol,2013, 85(1):55-64.

[24] Uyeki TM, Cox concerns regarding novel influenza A (H7N9) virus infections[J].N Engl J Med,2013, 368(20):1862-1864.

[25] Mlakar J, Korva M, Tul N, et al.Zika virus associated with microcephaly[J].N Engl J Med, 2016, 374(10):951-958.

[26] WHO Ebola Response virus disease in West Africa--the first 9 months of the epidemic and forward projections[J].N Engl J Med, 2014, 371(16):1481-1495.

[27] Zyoud research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis[J].BMC Infect Dis, 2016, 16:255.

[28] Bose biology: a biologist’s viewpoint[J].Prog Biophys Mol Biol, 2013, 113(3):358-368.

[29] Hochberg J, Khaled S, Forman SJ, et for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in fi rst complete remission[J].Br J Haematol, 2013, 161(1):27-42.

[30] Moyé LA, Simari RD, Skarlatos SI.Bone marrow-derived cell therapy after myocardial infarction[J].JAMA, 2013,309(14):1459.

[31] Harn HJ, Lin SZ, Hung SH, et stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function[J].Cell Transplant,2012, 21(12):2753-2764.

[32] Bennet L, Tan S, Van den Heuij L, et al.Cell therapy for neonatal hypoxia-ischemia and cerebral palsy[J].Ann Neurol, 2012, 71(5):589-600.

[33] Wilson JG, Liu KD, Zhuo H, et stem(stromal) cells for treatment of ARDS: a phase 1 clinical trial[J].Lancet Respir Med, 2015, 3(1):24-32.

文章来源：《上海经济研究》网址: http://www.shjjyjzz.cn/qikandaodu/2021/0208/628.html